Skip to content

Enovis ENOV Prevention & Recovery — Depreciation

Other segment segments

Reconstructive
$25.73M+3.5%

Similar metrics at other companies

US Physical Therapy logo
USPHIndustrial Injury Prevention Services Revenues — Depreciation And Amortization Of Segments
$908K+7.2%
Baxter International logo
BAXMedical Products & Therapies — Depreciation
$51M+4.1%
Trimas logo
TRSCorporate Segment — Depreciation, Depletion and Amortization
$110K+37.5%
Weatherford International logo
WFRDPRI — D&A
$24M+33.3%
Robert Half logo
RHIProtiviti — Depreciation
$4.3M-2.5%
Brunswick logo
BCCorporate Segment — Depreciation
$1.3M+8.3%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's prevention & recovery — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's prevention & recovery — depreciation?
Enovis (ENOV) reported prevention & recovery — depreciation of $5.07M in Q1 2026.
What does prevention & recovery — depreciation mean?
This metric tracks the periodic allocation of the cost of tangible assets used within the Prevention & Recovery segment over their useful lives. It reflects the wear and tear or obsolescence of manufacturing equipment and infrastructure dedicated to rehabilitation and pain management products. Analyzing this expense provides insight into the capital intensity of the segment and the ongoing investment required to maintain its operational capacity.